Cambridge Cognition Holdings's ROE % for the quarter that ended in Dec. 2025 was -50.16%. Cambridge Cognition Holdings's PB Ratio for the quarter that ended in Dec. 2025 was 4.38.
Cambridge Cognition Holdings's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -11.45%.
Cambridge Cognition Holdings ROE % Adjusted to Book Value Related Terms
Cambridge Cognition Holdings ROE % Adjusted to Book Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Cognition Holdings ROE % Adjusted to Book Value Chart
LSE:COG vs VEEV, BTSG, TEM: ROE % Adjusted to Book Value Comparison
For the Health Information Services subindustry, Cambridge Cognition Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cambridge Cognition Holdings ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cambridge Cognition Holdings's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Cambridge Cognition Holdings's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -11.45% mean?
Cambridge Cognition Holdings (LSE:COG) has a ROE % Adjusted to Book Value of -11.45% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Cambridge Cognition Holdings and its competitors.
Is Cambridge Cognition Holdings' ROE % Adjusted to Book Value too high?
Cambridge Cognition Holdings' current ROE % Adjusted to Book Value is -11.45%. Overall, Cambridge Cognition Holdings has a GF Score™ of 46/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cambridge Cognition Holdings' ROE % Adjusted to Book Value compare to VEEV and BTSG?
Cambridge Cognition Holdings' ROE % Adjusted to Book Value of -11.45% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Cambridge Cognition Holdings and its competitors. Cambridge Cognition Holdings's current ROE % Adjusted to Book Value is -11.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Cognition Holdings stock overvalued right now?
Based on GuruFocus' analysis, Cambridge Cognition Holdings (LSE:COG) is currently considered Fairly Valued. The stock's GF Value™ is £0.33, compared to a current price of £0.34 — trading 1.5% above its estimated fair value. The current ROE % Adjusted to Book Value is -11.45%. Cambridge Cognition Holdings' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Cambridge Cognition Holdings (LSE:COG), the current ROE % Adjusted to Book Value is -11.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cambridge Cognition Holdings (LSE:COG) Overvalued in 2026?
Based on GuruFocus' analysis, Cambridge Cognition Holdings stock appears to be overvalued.
The current stock price of £0.34 is trading 1.5% above its estimated GF Value™ of £0.33.
GuruFocus considers Cambridge Cognition Holdings to be Fairly Valued.
Key valuation signals for LSE:COG:
ROE % Adjusted to Book Value: -11.45%
GF Value™: £0.33 vs. price of £0.34 (1.5% above fair value)
No single metric tells the full story. See the LSE:COG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the measurement of clinical outcomes in neurological disorders. It develops and commercialises neuroscience technologies to assess cognitive function for sale across the world. The company's products include CANTAB web-based assessments, Electronic questionnaires and scales (eCOA), NeuroVocalix Winterlight, a voice analysis tool to assess cognitive changes, high-frequency testing kits, and Clinpal, among others. Its operating segments are: Clinical studies, which generate maximum revenue, Academic research, Professional Healthcare, and Consumer Health & Wellness. Geographically, the company generates maximum revenue from the USA, and the rest from the UK, the European Union, and the Rest of the world.
46GF Score
Get the complete analysis for LSE:COG
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:COG has been successfully added to your 
